<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37408187</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>09</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Live Cell Imaging of ATP Levels Reveals Metabolic Compartmentalization within Motoneurons and Early Metabolic Changes in <i>FUS</i> ALS Motoneurons.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1352</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells12101352</ELocationID><Abstract><AbstractText>Motoneurons are one of the most energy-demanding cell types and a primary target in Amyotrophic lateral sclerosis (ALS), a debilitating and lethal neurodegenerative disorder without currently available effective treatments. Disruption of mitochondrial ultrastructure, transport, and metabolism is a commonly reported phenotype in ALS models and can critically affect survival and the proper function of motor neurons. However, how changes in metabolic rates contribute to ALS progression is not fully understood yet. Here, we utilize hiPCS-derived motoneuron cultures and live imaging quantitative techniques to evaluate metabolic rates in fused in sarcoma (FUS)-ALS model cells. We show that differentiation and maturation of motoneurons are accompanied by an overall upregulation of mitochondrial components and a significant increase in metabolic rates that correspond to their high energy-demanding state. Detailed compartment-specific live measurements using a fluorescent ATP sensor and FLIM imaging show significantly lower levels of ATP in the somas of cells carrying FUS-ALS mutations. These changes lead to the increased vulnerability of diseased motoneurons to further metabolic challenges with mitochondrial inhibitors and could be due to the disruption of mitochondrial inner membrane integrity and an increase in its proton leakage. Furthermore, our measurements demonstrate heterogeneity between axonal and somatic compartments, with lower relative levels of ATP in axons. Our observations strongly support the hypothesis that mutated FUS impacts the metabolic states of motoneurons and makes them more susceptible to further neurodegenerative mechanisms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zimyanin</LastName><ForeName>Vitaly L</ForeName><Initials>VL</Initials><Identifier Source="ORCID">0000-0001-8601-4451</Identifier><AffiliationInfo><Affiliation>Department of Molecular Physiology and Biological Physics, School of Medicine, University of Virginia, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Membrane and Cell Physiology, School of Medicine, University of Virginia, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pielka</LastName><ForeName>Anna-Maria</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Translational Neurodegeneration Section, "Albrecht Kossel", Department of Neurology, University Medical Center Rostock, University of Rostock, 18147 Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gla&#xdf;</LastName><ForeName>Hannes</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-3155-5300</Identifier><AffiliationInfo><Affiliation>Translational Neurodegeneration Section, "Albrecht Kossel", Department of Neurology, University Medical Center Rostock, University of Rostock, 18147 Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Japtok</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gro&#xdf;mann</LastName><ForeName>Dajana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Translational Neurodegeneration Section, "Albrecht Kossel", Department of Neurology, University Medical Center Rostock, University of Rostock, 18147 Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Physiology, Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deussen</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Physiology, Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szewczyk</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Translational Neurodegeneration Section, "Albrecht Kossel", Department of Neurology, University Medical Center Rostock, University of Rostock, 18147 Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deppmann</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biology, Graduate School of Arts and Sciences, University of Virginia, Charlottesville, VA 22902, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zunder</LastName><ForeName>Eli</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, School of Medicine, University of Virginia, Charlottesville, VA 22902, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Peter M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, Neurosciences, Ume&#xe5; University, SE-901 85 Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boeckers</LastName><ForeName>Tobias M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Neurodegenerative Erkrankungen (DZNE), Ulm Site, 89081 Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Anatomy and Cell Biology, Ulm University, 89081 Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sterneckert</LastName><ForeName>Jared</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre for Regenerative Therapie, Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Faculty Carl Gustav Carus, Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Redemann</LastName><ForeName>Stefanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Molecular Physiology and Biological Physics, School of Medicine, University of Virginia, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Membrane and Cell Physiology, School of Medicine, University of Virginia, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell Biology, School of Medicine, University of Virginia, Charlottesville, VA 22902, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Storch</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Neurodegenerative Erkrankungen (DZNE) Rostock/Greifswald, 18147 Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Transdisciplinary Neurosciences Rostock (CTNR), University Medical Centre, University of Rostock, 18147 Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of Rostock, 18147 Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hermann</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7364-7791</Identifier><AffiliationInfo><Affiliation>Translational Neurodegeneration Section, "Albrecht Kossel", Department of Neurology, University Medical Center Rostock, University of Rostock, 18147 Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Neurodegenerative Erkrankungen (DZNE) Rostock/Greifswald, 18147 Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Transdisciplinary Neurosciences Rostock (CTNR), University Medical Centre, University of Rostock, 18147 Rostock, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>S10 OD025156</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS111220</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS091617</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>8L70Q75FXE</RegistryNumber><NameOfSubstance UI="D000255">Adenosine Triphosphate</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000255" MajorTopicYN="N">Adenosine Triphosphate</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">metabolism</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>6</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37408187</ArticleId><ArticleId IdType="pmc">PMC10216752</ArticleId><ArticleId IdType="doi">10.3390/cells12101352</ArticleId><ArticleId IdType="pii">cells12101352</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017;377:1602. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">29045202</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Brown R.H., Cleveland D.W. Decoding ALS: From genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M., Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: What do we really know? Nat. Rev. Neurol. 2011;7:603&#x2013;615. doi: 10.1038/nrneurol.2011.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.150</ArticleId><ArticleId IdType="pubmed">21989245</ArticleId></ArticleIdList></Reference><Reference><Citation>Boylan K. Familial Amyotrophic Lateral Sclerosis. Neurol. Clin. 2015;33:807&#x2013;830. doi: 10.1016/j.ncl.2015.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.001</ArticleId><ArticleId IdType="pmc">PMC4670044</ArticleId><ArticleId IdType="pubmed">26515623</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J., Comley L.H., Hedlund E. Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:863&#x2013;885. doi: 10.1007/s00401-017-1708-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1708-8</ArticleId><ArticleId IdType="pmc">PMC5427160</ArticleId><ArticleId IdType="pubmed">28409282</ArticleId></ArticleIdList></Reference><Reference><Citation>Magran&#xe9; J., Cortez C., Gan W.B., Manfredi G. Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models. Human Mol. Genet. 2014;23:1413&#x2013;1424. doi: 10.1093/hmg/ddt528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt528</ArticleId><ArticleId IdType="pmc">PMC3929084</ArticleId><ArticleId IdType="pubmed">24154542</ArticleId></ArticleIdList></Reference><Reference><Citation>Altman T., Geller D., Kleeblatt E., Gradus-Perry T., Perlson E. An in vitro compartmental system underlines the contribution of mitochondrial immobility to the ATP supply in the NMJ. J. Cell Sci. 2019;132:jcs234492. doi: 10.1242/jcs.234492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.234492</ArticleId><ArticleId IdType="pubmed">31722980</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandoorne T., De Bock K., Van Den Bosch L. Energy metabolism in ALS: An underappreciated opportunity? Acta Neuropathol. 2018;135:489&#x2013;509. doi: 10.1007/s00401-018-1835-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1835-x</ArticleId><ArticleId IdType="pmc">PMC5978930</ArticleId><ArticleId IdType="pubmed">29549424</ArticleId></ArticleIdList></Reference><Reference><Citation>Borthwick G.M., Johnson M.A., Ince P.G., Shaw P.J., Turnbull D.M. Mitochondrial enzyme activity in amyotrophic lateral sclerosis: Implications for the role of mitochondria in neuronal cell death. Ann. Neurol. 1999;46:787&#x2013;790. doi: 10.1002/1531-8249(199911)46:5&lt;787::AID-ANA17&gt;3.0.CO;2-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1531-8249(199911)46:5&lt;787::AID-ANA17&gt;3.0.CO;2-8</ArticleId><ArticleId IdType="pubmed">10553999</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandoorne T., Veys K., Guo W., Sicart A., Vints K., Swijsen A., Moisse M., Eelen G., Gounko N.V., Fumagalli L., et al. Differentiation but not ALS mutations in FUS rewires motor neuron metabolism. Nat. Commun. 2019;10:4147. doi: 10.1038/s41467-019-12099-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12099-4</ArticleId><ArticleId IdType="pmc">PMC6742665</ArticleId><ArticleId IdType="pubmed">31515480</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai Y.L., Coady T.H., Lu L., Zheng D., Alland I., Tian B., Shneider N.A., Manley J.L. ALS/FTD-associated protein FUS induces mitochondrial dysfunction by preferentially sequestering respiratory chain complex mRNAs. Genes. Dev. 2020;34:785&#x2013;805. doi: 10.1101/gad.335836.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.335836.119</ArticleId><ArticleId IdType="pmc">PMC7263147</ArticleId><ArticleId IdType="pubmed">32381627</ArticleId></ArticleIdList></Reference><Reference><Citation>Muddapu V.R., Dharshini S.A.P., Chakravarthy V.S., Gromiha M.M. Neurodegenerative Diseases&#x2014;Is Metabolic Deficiency the Root Cause? Front. Neurosci. 2020;14:213. doi: 10.3389/fnins.2020.00213.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00213</ArticleId><ArticleId IdType="pmc">PMC7137637</ArticleId><ArticleId IdType="pubmed">32296300</ArticleId></ArticleIdList></Reference><Reference><Citation>So E., Mitchell J.C., Memmi C., Chennell G., Vizcay-Barrena G., Allison L., Shaw C.E., Vance C. Mitochondrial abnormalities and disruption of the neuromuscular junction precede the clinical phenotype and motor neuron loss in hFUSWT transgenic mice. Human Mol. Genet. 2018;27:463&#x2013;474. doi: 10.1093/hmg/ddx415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx415</ArticleId><ArticleId IdType="pmc">PMC5886082</ArticleId><ArticleId IdType="pubmed">29194538</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J., Wang P., Chen X., Cheng H., Liu J., Fushimi K., Zhu L., Wu J.Y. FUS interacts with ATP synthase beta subunit and induces mitochondrial unfolded protein response in cellular and animal models. Proc. Natl. Acad. Sci. USA. 2018;115:E9678&#x2013;E9686. doi: 10.1073/pnas.1806655115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1806655115</ArticleId><ArticleId IdType="pmc">PMC6187197</ArticleId><ArticleId IdType="pubmed">30249657</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T., Jiang X., Chen G., Xu J. Interaction of amyotrophic lateral sclerosis/frontotemporal lobar degeneration-associated fused-in-sarcoma with proteins involved in metabolic and protein degradation pathways. Neurobiol. Aging. 2015;36:527&#x2013;535. doi: 10.1016/j.neurobiolaging.2014.07.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.07.044</ArticleId><ArticleId IdType="pubmed">25192599</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoica R., Paillusson S., Gomez-Suaga P., Mitchell J.C., Lau D.H., Gray E.H., Sancho R.M., Vizcay-Barrena G., De Vos K.J., Shaw C.E., et al. ALS/FTD-associated FUS activates GSK-3&#x3b2; to disrupt the VAPB-PTPIP51 interaction and ER-mitochondria associations. EMBO Rep. 2016;17:1326&#x2013;1342. doi: 10.15252/embr.201541726.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201541726</ArticleId><ArticleId IdType="pmc">PMC5007559</ArticleId><ArticleId IdType="pubmed">27418313</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal A., Kretner B., Abo-Rady M., Gla&#x3b2; H., Dash B.P., Naumann M., Japtok J., Kreiter N., Dhingra A., Heutink P., et al. Concomitant gain and loss of function pathomechanisms in C9ORF72 amyotrophic lateral sclerosis. Life Sci. Alliance. 2021;4 doi: 10.26508/lsa.202000764.</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.202000764</ArticleId><ArticleId IdType="pmc">PMC7918691</ArticleId><ArticleId IdType="pubmed">33619157</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;nther R., Pal A., Williams C., Zimyanin V.L., Liehr M., von Neubeck C., Krause M., Parab M.G., Petri S., Kalmbach N., et al. Alteration of Mitochondrial Integrity as Upstream Event in the Pathophysiology of SOD1-ALS. Cells. 2022;11:1246. doi: 10.3390/cells11071246.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11071246</ArticleId><ArticleId IdType="pmc">PMC8997900</ArticleId><ArticleId IdType="pubmed">35406813</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreiter N., Pal A., Lojewski X., Corcia P., Naujock M., Reinhardt P., Sterneckert J., Petri S., Wegner F., Storch A., et al. Age-dependent neurodegeneration and organelle transport deficiencies in mutant TDP43 patient-derived neurons are independent of TDP43 aggregation. Neurobiol. Dis. 2018;115:167&#x2013;181. doi: 10.1016/j.nbd.2018.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.03.010</ArticleId><ArticleId IdType="pubmed">29630989</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W., Naujock M., Fumagalli L., Vandoorne T., Baatsen P., Boon R., Ordov&#xe1;s L., Patel A., Welters M., Vanwelden T., et al. HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients. Nat. Commun. 2017;8:861. doi: 10.1038/s41467-017-00911-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00911-y</ArticleId><ArticleId IdType="pmc">PMC5636840</ArticleId><ArticleId IdType="pubmed">29021520</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge J.C., Treleaven C.M., Fidler J.A., Tamsett T.J., Bao C., Searles M., Taksir T.V., Misra K., Sidman R.L., Cheng S.H., et al. Metabolic signatures of amyotrophic lateral sclerosis reveal insights into disease pathogenesis. Proc. Natl. Acad. Sci. USA. 2013;110:10812&#x2013;10817. doi: 10.1073/pnas.1308421110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1308421110</ArticleId><ArticleId IdType="pmc">PMC3696768</ArticleId><ArticleId IdType="pubmed">23754387</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawaid A., Salamone A.R., Strutt A.M., Murthy S.B., Wheaton M., McDowell E.J., Simpson E., Appel S.H., York M.K., Schulz P.E. ALS disease onset may occur later in patients with pre-morbid diabetes mellitus. Eur. J. Neurol. 2010;17:733&#x2013;739. doi: 10.1111/j.1468-1331.2009.02923.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2009.02923.x</ArticleId><ArticleId IdType="pubmed">20074230</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M., Pal A., Goswami A., Lojewski X., Japtok J., Vehlow A., Naujock M., Gunther R., Jin M., Stanslowsky N., et al. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nat. Commun. 2018;9:335. doi: 10.1038/s41467-017-02299-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02299-1</ArticleId><ArticleId IdType="pmc">PMC5780468</ArticleId><ArticleId IdType="pubmed">29362359</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainger B.J., Kiskinis E., Mellin C., Wiskow O., Han S.S., Sandoe J., Perez N.P., Williams L.A., Lee S., Boulting G., et al. Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. Cell Rep. 2014;7:1&#x2013;11. doi: 10.1016/j.celrep.2014.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.03.019</ArticleId><ArticleId IdType="pmc">PMC4023477</ArticleId><ArticleId IdType="pubmed">24703839</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakaya T., Maragkakis M. Amyotrophic Lateral Sclerosis associated FUS mutation shortens mitochondria and induces neurotoxicity. Sci. Rep. 2018;8:15575. doi: 10.1038/s41598-018-33964-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-33964-0</ArticleId><ArticleId IdType="pmc">PMC6197261</ArticleId><ArticleId IdType="pubmed">30349096</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Chen J., Liu W., Li X., Chen Q., Liu T., Gao S., Deng M. The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation. Neurogenetics. 2015;16:223&#x2013;231. doi: 10.1007/s10048-015-0448-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-015-0448-y</ArticleId><ArticleId IdType="pubmed">25912081</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang Y., Huang E.J. Mechanisms of FUS mutations in familial amyotrophic lateral sclerosis. Brain Res. 2016;1647:65&#x2013;78. doi: 10.1016/j.brainres.2016.03.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.03.036</ArticleId><ArticleId IdType="pmc">PMC5003642</ArticleId><ArticleId IdType="pubmed">27033831</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H., Gao K., Jankovic J. The role of FUS gene variants in neurodegenerative diseases. Nat. Rev. Neurol. 2014;10:337&#x2013;348. doi: 10.1038/nrneurol.2014.78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.78</ArticleId><ArticleId IdType="pubmed">24840975</ArticleId></ArticleIdList></Reference><Reference><Citation>Renger R., Morin J.A., Lemaitre R., Ruer-Gruss M., Julicher F., Hermann A., Grill S.W. Co-condensation of proteins with single- and double-stranded DNA. Proc. Natl. Acad. Sci. USA. 2022;119:e2107871119. doi: 10.1073/pnas.2107871119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2107871119</ArticleId><ArticleId IdType="pmc">PMC8915884</ArticleId><ArticleId IdType="pubmed">35238639</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Gal J., Chen J., Zhu H. Self-assembled FUS binds active chromatin and regulates gene transcription. Proc. Natl. Acad. Sci. USA. 2014;111:17809&#x2013;17814. doi: 10.1073/pnas.1414004111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1414004111</ArticleId><ArticleId IdType="pmc">PMC4273402</ArticleId><ArticleId IdType="pubmed">25453086</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogelj B., Easton L.E., Bogu G.K., Stanton L.W., Rot G., Curk T., Zupan B., Sugimoto Y., Modic M., Haberman N., et al. Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain. Sci. Rep. 2012;2:603. doi: 10.1038/srep00603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep00603</ArticleId><ArticleId IdType="pmc">PMC3429604</ArticleId><ArticleId IdType="pubmed">22934129</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Polymenidou M., Hutt K.R., Vu A.Q., Baughn M., Huelga S.C., Clutario K.M., Ling S.C., Liang T.Y., Mazur C., et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 2012;15:1488&#x2013;1497. doi: 10.1038/nn.3230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3230</ArticleId><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishigaki S., Masuda A., Fujioka Y., Iguchi Y., Katsuno M., Shibata A., Urano F., Sobue G., Ohno K. Position-dependent FUS-RNA interactions regulate alternative splicing events and transcriptions. Sci. Rep. 2012;2:529. doi: 10.1038/srep00529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep00529</ArticleId><ArticleId IdType="pmc">PMC3402842</ArticleId><ArticleId IdType="pubmed">22829983</ArticleId></ArticleIdList></Reference><Reference><Citation>Banani S.F., Rice A.M., Peeples W.B., Lin Y., Jain S., Parker R., Rosen M.K. Compositional Control of Phase-Separated Cellular Bodies. Cell. 2016;166:651&#x2013;663. doi: 10.1016/j.cell.2016.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.06.010</ArticleId><ArticleId IdType="pmc">PMC4967043</ArticleId><ArticleId IdType="pubmed">27374333</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciryam P., Tartaglia G.G., Morimoto R.I., Dobson C.M., Vendruscolo M. Widespread aggregation and neurodegenerative diseases are associated with supersaturated proteins. Cell Rep. 2013;5:781&#x2013;790. doi: 10.1016/j.celrep.2013.09.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.09.043</ArticleId><ArticleId IdType="pmc">PMC3883113</ArticleId><ArticleId IdType="pubmed">24183671</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A., Lee H.O., Jawerth L., Maharana S., Jahnel M., Hein M.Y., Stoynov S., Mahamid J., Saha S., Franzmann T.M., et al. A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation. Cell. 2015;162:1066&#x2013;1077. doi: 10.1016/j.cell.2015.07.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.07.047</ArticleId><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A., Malinovska L., Saha S., Wang J., Alberti S., Krishnan Y., Hyman A.A. ATP as a biological hydrotrope. Science. 2017;356:753&#x2013;756. doi: 10.1126/science.aaf6846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf6846</ArticleId><ArticleId IdType="pubmed">28522535</ArticleId></ArticleIdList></Reference><Reference><Citation>Han T.W., Kato M., Xie S., Wu L.C., Mirzaei H., Pei J., Chen M., Xie Y., Allen J., Xiao G., et al. Cell-free formation of RNA granules: Bound RNAs identify features and components of cellular assemblies. Cell. 2012;149:768&#x2013;779. doi: 10.1016/j.cell.2012.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.04.016</ArticleId><ArticleId IdType="pubmed">22579282</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato M., Han T.W., Xie S., Shi K., Du X., Wu L.C., Mirzaei H., Goldsmith E.J., Longgood J., Pei J., et al. Cell-free formation of RNA granules: Low complexity sequence domains form dynamic fibers within hydrogels. Cell. 2012;149:753&#x2013;767. doi: 10.1016/j.cell.2012.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.04.017</ArticleId><ArticleId IdType="pmc">PMC6347373</ArticleId><ArticleId IdType="pubmed">22579281</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A., Temirov J., Lee J., Coughlin M., Kanagaraj A.P., Kim H.J., Mittag T., Taylor J.P. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell. 2015;163:123&#x2013;133. doi: 10.1016/j.cell.2015.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.09.015</ArticleId><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Kim N.C., Wang Y.D., Scarborough E.A., Moore J., Diaz Z., MacLea K.S., Freibaum B., Li S., Molliex A., et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013;495:467&#x2013;473. doi: 10.1038/nature11922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11922</ArticleId><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami T., Qamar S., Lin J.Q., Schierle G.S., Rees E., Miyashita A., Costa A.R., Dodd R.B., Chan F.T., Michel C.H., et al. ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function. Neuron. 2015;88:678&#x2013;690. doi: 10.1016/j.neuron.2015.10.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.10.030</ArticleId><ArticleId IdType="pmc">PMC4660210</ArticleId><ArticleId IdType="pubmed">26526393</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli E.T., Lasseigne B.N., Petrovski S., Sapp P.C., Dion P.A., Leblond C.S., Couthouis J., Lu Y.F., Wang Q., Krueger B.J., et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347:1436&#x2013;1441. doi: 10.1126/science.aaa3650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa3650</ArticleId><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H.X., Chen W., Hong S.T., Boycott K.M., Gorrie G.H., Siddique N., Yang Y., Fecto F., Shi Y., Zhai H., et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011;477:211&#x2013;215. doi: 10.1038/nature10353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10353</ArticleId><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Majcher V., Goode A., James V., Layfield R. Autophagy receptor defects and ALS-FTLD. Mol. Cell Neurosci. 2015;66:43&#x2013;52. doi: 10.1016/j.mcn.2015.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2015.01.002</ArticleId><ArticleId IdType="pubmed">25683489</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuno Y., Amari M., Takatama M., Aizawa H., Mihara B., Okamoto K. Immunoreactivities of p62, an ubiqutin-binding protein, in the spinal anterior horn cells of patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 2006;249:13&#x2013;18. doi: 10.1016/j.jns.2006.05.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2006.05.060</ArticleId><ArticleId IdType="pubmed">16820172</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramaswami M., Taylor J.P., Parker R. Altered ribostasis: RNA-protein granules in degenerative disorders. Cell. 2013;154:727&#x2013;736. doi: 10.1016/j.cell.2013.07.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.07.038</ArticleId><ArticleId IdType="pmc">PMC3811119</ArticleId><ArticleId IdType="pubmed">23953108</ArticleId></ArticleIdList></Reference><Reference><Citation>Szewczyk B., G&#xfc;nther R., Japtok J., Frech M.J., Naumann M., Lee H.O., Hermann A. FUS ALS neurons activate major stress pathways and reduce translation as an early protective mechanism against neurodegeneration. Cell Rep. 2023;42:112025. doi: 10.1016/j.celrep.2023.112025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2023.112025</ArticleId><ArticleId IdType="pubmed">36696267</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain S., Wheeler J.R., Walters R.W., Agrawal A., Barsic A., Parker R. ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. Cell. 2016;164:487&#x2013;498. doi: 10.1016/j.cell.2015.12.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.12.038</ArticleId><ArticleId IdType="pmc">PMC4733397</ArticleId><ArticleId IdType="pubmed">26777405</ArticleId></ArticleIdList></Reference><Reference><Citation>Parry B.R., Surovtsev I.V., Cabeen M.T., O&#x2019;Hern C.S., Dufresne E.R., Jacobs-Wagner C. The bacterial cytoplasm has glass-like properties and is fluidized by metabolic activity. Cell. 2014;156:183&#x2013;194. doi: 10.1016/j.cell.2013.11.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.11.028</ArticleId><ArticleId IdType="pmc">PMC3956598</ArticleId><ArticleId IdType="pubmed">24361104</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhardt P., Glatza M., Hemmer K., Tsytsyura Y., Thiel C.S., Hoing S., Moritz S., Parga J.A., Wagner L., Bruder J.M., et al. Derivation and expansion using only small molecules of human neural progenitors for neurodegenerative disease modeling. PLoS ONE. 2013;8:e59252. doi: 10.1371/annotation/6a917a2e-df4a-4ad9-99bb-6aa7218b833e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/annotation/6a917a2e-df4a-4ad9-99bb-6aa7218b833e</ArticleId><ArticleId IdType="pmc">PMC3606479</ArticleId><ArticleId IdType="pubmed">23533608</ArticleId></ArticleIdList></Reference><Reference><Citation>Japtok J., Lojewski X., Naumann M., Klingenstein M., Reinhardt P., Sterneckert J., Putz S., Demestre M., Boeckers T.M., Ludolph A.C., et al. Stepwise acquirement of hallmark neuropathology in FUS-ALS iPSC models depends on mutation type and neuronal aging. Neurobiol. Dis. 2015;82:420&#x2013;429. doi: 10.1016/j.nbd.2015.07.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.07.017</ArticleId><ArticleId IdType="pubmed">26253605</ArticleId></ArticleIdList></Reference><Reference><Citation>Haink G., Deussen A. Liquid chromatography method for the analysis of adenosine compounds. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2003;784:189&#x2013;193. doi: 10.1016/S1570-0232(02)00752-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1570-0232(02)00752-3</ArticleId><ArticleId IdType="pubmed">12504197</ArticleId></ArticleIdList></Reference><Reference><Citation>Maldonado E.N., Lemasters J.J. ATP/ADP ratio, the missed connection between mitochondria and the Warburg effect. Mitochondrion. 2014;19 Pt A:78&#x2013;84. doi: 10.1016/j.mito.2014.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2014.09.002</ArticleId><ArticleId IdType="pmc">PMC4254332</ArticleId><ArticleId IdType="pubmed">25229666</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkinson D.E. The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Biochemistry. 1968;7:4030&#x2013;4034. doi: 10.1021/bi00851a033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00851a033</ArticleId><ArticleId IdType="pubmed">4972613</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos-Salazar A., Baines A.D. Fluorometric determination of adenine nucleotides and adenosine by ion-paired, reverse-phase, high-performance liquid chromatography. Anal. Biochem. 1985;145:9&#x2013;13. doi: 10.1016/0003-2697(85)90319-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-2697(85)90319-7</ArticleId><ArticleId IdType="pubmed">4003764</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao R., Wallrabe H., Siller K., Rehman Alam S., Periasamy A. Single-cell redox states analyzed by fluorescence lifetime metrics and tryptophan FRET interaction with NAD(P)H. Cytometry A. 2019;95:110&#x2013;121. doi: 10.1002/cyto.a.23711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cyto.a.23711</ArticleId><ArticleId IdType="pubmed">30604477</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallrabe H., Svindrych Z., Alam S.R., Siller K.H., Wang T., Kashatus D., Hu S., Periasamy A. Segmented cell analyses to measure redox states of autofluorescent NAD(P)H, FAD &amp; Trp in cancer cells by FLIM. Sci. Rep. 2018;8:79. doi: 10.1038/s41598-017-18634-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-18634-x</ArticleId><ArticleId IdType="pmc">PMC5758727</ArticleId><ArticleId IdType="pubmed">29311591</ArticleId></ArticleIdList></Reference><Reference><Citation>Imamura H., Nhat K.P., Togawa H., Saito K., Iino R., Kato-Yamada Y., Nagai T., Noji H. Visualization of ATP levels inside single living cells with fluorescence resonance energy transfer-based genetically encoded indicators. Proc. Natl. Acad. Sci. USA. 2009;106:15651&#x2013;15656. doi: 10.1073/pnas.0904764106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0904764106</ArticleId><ArticleId IdType="pmc">PMC2735558</ArticleId><ArticleId IdType="pubmed">19720993</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbab M., Baars S., Geijsen N. Modeling motor neuron disease: The matter of time. Trends Neurosci. 2014;37:642&#x2013;652. doi: 10.1016/j.tins.2014.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2014.07.008</ArticleId><ArticleId IdType="pubmed">25156326</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawrot J., Imhof S., Wainger B.J. Modeling cell-autonomous motor neuron phenotypes in ALS using iPSCs. Neurobiol. Dis. 2020;134:104680. doi: 10.1016/j.nbd.2019.104680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104680</ArticleId><ArticleId IdType="pmc">PMC7002167</ArticleId><ArticleId IdType="pubmed">31759135</ArticleId></ArticleIdList></Reference><Reference><Citation>Traxler L., Edenhofer F., Mertens J. Next-generation disease modeling with direct conversion: A new path to old neurons. FEBS Lett. 2019;593:3316&#x2013;3337. doi: 10.1002/1873-3468.13678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.13678</ArticleId><ArticleId IdType="pmc">PMC6907729</ArticleId><ArticleId IdType="pubmed">31715002</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziff O.J., Patani R. Harnessing cellular aging in human stem cell models of amyotrophic lateral sclerosis. Aging Cell. 2019;18:e12862. doi: 10.1111/acel.12862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12862</ArticleId><ArticleId IdType="pmc">PMC6351881</ArticleId><ArticleId IdType="pubmed">30565851</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucchia M., Merwin S.J., Re D.B., Kariya S. Limitations and Challenges in Modeling Diseases Involving Spinal Motor Neuron Degeneration. Front. Cell Neurosci. 2018;12:61. doi: 10.3389/fncel.2018.00061.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00061</ArticleId><ArticleId IdType="pmc">PMC5845677</ArticleId><ArticleId IdType="pubmed">29559895</ArticleId></ArticleIdList></Reference><Reference><Citation>Belzil V.V., Langlais J.S., Daoud H., Dion P.A., Brais B., Rouleau G.A. Novel FUS deletion in a patient with juvenile amyotrophic lateral sclerosis. Arch. Neurol. 2012;69:653&#x2013;656. doi: 10.1001/archneurol.2011.2499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.2499</ArticleId><ArticleId IdType="pubmed">22248478</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrone L., Drexler H.C.A., Wang J., Tripathi P., Distler T., Heisterkamp P., Anderson E.N., Kour S., Moraiti A., Maharana S., et al. FUS pathology in ALS is linked to alterations in multiple ALS-associated proteins and rescued by drugs stimulating autophagy. Acta Neuropathol. 2019;138:67&#x2013;84. doi: 10.1007/s00401-019-01998-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01998-x</ArticleId><ArticleId IdType="pmc">PMC6570784</ArticleId><ArticleId IdType="pubmed">30937520</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D., Madl T., Valori C.F., Bentmann E., Tahirovic S., Abou-Ajram C., Kremmer E., Ansorge O., Mackenzie I.R., Neumann M., et al. Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS. EMBO J. 2012;31:4258&#x2013;4275. doi: 10.1038/emboj.2012.261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2012.261</ArticleId><ArticleId IdType="pmc">PMC3501225</ArticleId><ArticleId IdType="pubmed">22968170</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrone L., Poser I., Casci I., Japtok J., Reinhardt P., Janosch A., Andree C., Lee H.O., Moebius C., Koerner E., et al. Isogenic FUS-eGFP iPSC Reporter Lines Enable Quantification of FUS Stress Granule Pathology that Is Rescued by Drugs Inducing Autophagy. Stem Cell Rep. 2018;10:375&#x2013;389. doi: 10.1016/j.stemcr.2017.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.12.018</ArticleId><ArticleId IdType="pmc">PMC5857889</ArticleId><ArticleId IdType="pubmed">29358088</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdin E. NAD&#x207a; in aging, metabolism, and neurodegeneration. Science. 2015;350:1208&#x2013;1213. doi: 10.1126/science.aac4854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aac4854</ArticleId><ArticleId IdType="pubmed">26785480</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilan D.S., Belousov V.V. Genetically encoded probes for NAD+/NADH monitoring. Free Radic. Biol. Med. 2016;100:32&#x2013;42. doi: 10.1016/j.freeradbiomed.2016.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2016.06.018</ArticleId><ArticleId IdType="pubmed">27387770</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Yang Y. Real-time and high-throughput analysis of mitochondrial metabolic states in living cells using genetically encoded NAD. Free Radic. Biol. Med. 2016;100:43&#x2013;52. doi: 10.1016/j.freeradbiomed.2016.05.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2016.05.027</ArticleId><ArticleId IdType="pubmed">27261194</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuenoud B., Ipek &#xd6;., Shevlyakova M., Beaumont M., Cunnane S.C., Gruetter R., Xin L. Brain NAD Is Associated With ATP Energy Production and Membrane Phospholipid Turnover in Humans. Front. Aging Neurosci. 2020;12:609517. doi: 10.3389/fnagi.2020.609517.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2020.609517</ArticleId><ArticleId IdType="pmc">PMC7772416</ArticleId><ArticleId IdType="pubmed">33390929</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Sauve A.A. NAD(+) metabolism: Bioenergetics, signaling and manipulation for therapy. Biochim. Biophys. Acta. 2016;1864:1787&#x2013;1800. doi: 10.1016/j.bbapap.2016.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2016.06.014</ArticleId><ArticleId IdType="pmc">PMC5521000</ArticleId><ArticleId IdType="pubmed">27374990</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt D.P., Chen X., Geiger J.D., Rosenberger T.A. A sensitive HPLC-based method to quantify adenine nucleotides in primary astrocyte cell cultures. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2012;889&#x2013;890:110&#x2013;115. doi: 10.1016/j.jchromb.2012.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchromb.2012.02.005</ArticleId><ArticleId IdType="pmc">PMC3299834</ArticleId><ArticleId IdType="pubmed">22382093</ArticleId></ArticleIdList></Reference><Reference><Citation>Menegollo M., Tessari I., Bubacco L., Szabadkai G. Determination of ATP, ADP, and AMP Levels by Reversed-Phase High-Performance Liquid Chromatography in Cultured Cells. Methods Mol. Biol. 2019;1925:223&#x2013;232. doi: 10.1007/978-1-4939-9018-4_19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-9018-4_19</ArticleId><ArticleId IdType="pubmed">30674030</ArticleId></ArticleIdList></Reference><Reference><Citation>Soboll S., Akerboom T.P., Schwenke W.D., Haase R., Sies H. Mitochondrial and cytosolic ATP/ADP ratios in isolated hepatocytes. A comparison of the digitonin method and the non-aqueous fractionation procedure. Biochem. J. 1980;192:951&#x2013;954. doi: 10.1042/bj1920951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj1920951</ArticleId><ArticleId IdType="pmc">PMC1162423</ArticleId><ArticleId IdType="pubmed">7236247</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida T., Alfaqaan S., Sasaoka N., Imamura H. Application of FRET-Based Biosensor &#x201c;ATeam&#x201d; for Visualization of ATP Levels in the Mitochondrial Matrix of Living Mammalian Cells. Methods Mol. Biol. 2017;1567:231&#x2013;243. doi: 10.1007/978-1-4939-6824-4_14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-6824-4_14</ArticleId><ArticleId IdType="pubmed">28276022</ArticleId></ArticleIdList></Reference><Reference><Citation>Jose M., Nair D.K., Reissner C., Hartig R., Zuschratter W. Photophysics of Clomeleon by FLIM: Discriminating excited state reactions along neuronal development. Biophys. J. 2007;92:2237&#x2013;2254. doi: 10.1529/biophysj.106.092841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1529/biophysj.106.092841</ArticleId><ArticleId IdType="pmc">PMC1861805</ArticleId><ArticleId IdType="pubmed">17172293</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta R., Gillette A., Stefely M., Skala M.C. Recent innovations in fluorescence lifetime imaging microscopy for biology and medicine. J. Biomed. Opt. 2021;26:070603. doi: 10.1117/1.JBO.26.7.070603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1117/1.JBO.26.7.070603</ArticleId><ArticleId IdType="pmc">PMC8271181</ArticleId><ArticleId IdType="pubmed">34247457</ArticleId></ArticleIdList></Reference><Reference><Citation>Meleshina A.V., Dudenkova V.V., Shirmanova M.V., Shcheslavskiy V.I., Becker W., Bystrova A.S., Cherkasova E.I., Zagaynova E.V. Probing metabolic states of differentiating stem cells using two-photon FLIM. Sci. Rep. 2016;6:21853. doi: 10.1038/srep21853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep21853</ArticleId><ArticleId IdType="pmc">PMC4766469</ArticleId><ArticleId IdType="pubmed">26911347</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloney E.B., de Winter F., Verhaagen J. ALS as a distal axonopathy: Molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Front. Neurosci. 2014;8:252. doi: 10.3389/fnins.2014.00252.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2014.00252</ArticleId><ArticleId IdType="pmc">PMC4132373</ArticleId><ArticleId IdType="pubmed">25177267</ArticleId></ArticleIdList></Reference><Reference><Citation>Frolkis V.V., Tanin S.A., Marcinko V.I., Kulchitsky O.K., Yasechko A.V. Axoplasmic transport of substances in motoneuronal axons of the spinal cord in old age. Mech. Ageing Dev. 1985;29:19&#x2013;28. doi: 10.1016/0047-6374(85)90043-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0047-6374(85)90043-0</ArticleId><ArticleId IdType="pubmed">2580193</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravera S., Podest&#xe0; M., Sabatini F., Dagnino M., Cilloni D., Fiorini S., Barla A., Frassoni F. Discrete Changes in Glucose Metabolism Define Aging. Sci. Rep. 2019;9:10347. doi: 10.1038/s41598-019-46749-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-46749-w</ArticleId><ArticleId IdType="pmc">PMC6637183</ArticleId><ArticleId IdType="pubmed">31316102</ArticleId></ArticleIdList></Reference><Reference><Citation>Castelli V., Benedetti E., Antonosante A., Catanesi M., Pitari G., Ippoliti R., Cimini A., d&#x2019;Angelo M. Neuronal Cells Rearrangement During Aging and Neurodegenerative Disease: Metabolism, Oxidative Stress and Organelles Dynamic. Front. Mol. Neurosci. 2019;12:132. doi: 10.3389/fnmol.2019.00132.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00132</ArticleId><ArticleId IdType="pmc">PMC6546816</ArticleId><ArticleId IdType="pubmed">31191244</ArticleId></ArticleIdList></Reference><Reference><Citation>Parihar M.S., Kunz E.A., Brewer G.J. Age-related decreases in NAD(P)H and glutathione cause redox declines before ATP loss during glutamate treatment of hippocampal neurons. J. Neurosci. Res. 2008;86:2339&#x2013;2352. doi: 10.1002/jnr.21679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.21679</ArticleId><ArticleId IdType="pubmed">18438923</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellerin L., Magistretti P.J. Glutamate uptake into astrocytes stimulates aerobic glycolysis: A mechanism coupling neuronal activity to glucose utilization. Proc. Natl. Acad. Sci. USA. 1994;91:10625&#x2013;10629. doi: 10.1073/pnas.91.22.10625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.22.10625</ArticleId><ArticleId IdType="pmc">PMC45074</ArticleId><ArticleId IdType="pubmed">7938003</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az-Garc&#xed;a C.M., Mongeon R., Lahmann C., Koveal D., Zucker H., Yellen G. Neuronal Stimulation Triggers Neuronal Glycolysis and Not Lactate Uptake. Cell Metab. 2017;26:361&#x2013;374.e364. doi: 10.1016/j.cmet.2017.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2017.06.021</ArticleId><ArticleId IdType="pmc">PMC5559896</ArticleId><ArticleId IdType="pubmed">28768175</ArticleId></ArticleIdList></Reference><Reference><Citation>Loaiza A., Porras O.H., Barros L.F. Glutamate triggers rapid glucose transport stimulation in astrocytes as evidenced by real-time confocal microscopy. J. Neurosci. 2003;23:7337&#x2013;7342. doi: 10.1523/JNEUROSCI.23-19-07337.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.23-19-07337.2003</ArticleId><ArticleId IdType="pmc">PMC6740433</ArticleId><ArticleId IdType="pubmed">12917367</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen S.P., Rajan S., Duffy L., Mortiboys H., Higginbottom A., Grierson A.J., Shaw P.J. Superoxide dismutase 1 mutation in a cellular model of amyotrophic lateral sclerosis shifts energy generation from oxidative phosphorylation to glycolysis. Neurobiol. Aging. 2014;35:1499&#x2013;1509. doi: 10.1016/j.neurobiolaging.2013.11.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.11.025</ArticleId><ArticleId IdType="pubmed">24439480</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T., Tian X., Kim H.B., Jang Y., Huang Z., Na C.H., Wang J. Intracellular energy controls dynamics of stress-induced ribonucleoprotein granules. Nat. Commun. 2022;13:5584. doi: 10.1038/s41467-022-33079-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33079-1</ArticleId><ArticleId IdType="pmc">PMC9508253</ArticleId><ArticleId IdType="pubmed">36151083</ArticleId></ArticleIdList></Reference><Reference><Citation>Beirowski B. Emerging evidence for compromised axonal bioenergetics and axoglial metabolic coupling as drivers of neurodegeneration. Neurobiol. Dis. 2022;170:105751. doi: 10.1016/j.nbd.2022.105751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2022.105751</ArticleId><ArticleId IdType="pubmed">35569720</ArticleId></ArticleIdList></Reference><Reference><Citation>Chamberlain K.A., Sheng Z.H. Mechanisms for the maintenance and regulation of axonal energy supply. J. Neurosci. Res. 2019;97:897&#x2013;913. doi: 10.1002/jnr.24411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.24411</ArticleId><ArticleId IdType="pmc">PMC6565461</ArticleId><ArticleId IdType="pubmed">30883896</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen H., Goldberg M.P. Creatine pretreatment protects cortical axons from energy depletion in vitro. Neurobiol. Dis. 2012;47:184&#x2013;193. doi: 10.1016/j.nbd.2012.03.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2012.03.037</ArticleId><ArticleId IdType="pmc">PMC3367034</ArticleId><ArticleId IdType="pubmed">22521466</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques E.P., Wyse A.T.S. Creatine as a Neuroprotector: An Actor that Can Play Many Parts. Neurotox. Res. 2019;36:411&#x2013;423. doi: 10.1007/s12640-019-00053-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-019-00053-7</ArticleId><ArticleId IdType="pubmed">31069754</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M., Peikert K., Gunther R., van der Kooi A.J., Aronica E., Hubers A., Danel V., Corcia P., Pan-Montojo F., Cirak S., et al. Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosis. Ann. Clin. Transl. Neurol. 2019;6:2384&#x2013;2394. doi: 10.1002/acn3.50930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.50930</ArticleId><ArticleId IdType="pmc">PMC6917314</ArticleId><ArticleId IdType="pubmed">31682085</ArticleId></ArticleIdList></Reference><Reference><Citation>Riechers S.P., Mojsilovic-Petrovic J., Belton T.B., Chakrabarty R.P., Garjani M., Medvedeva V., Dalton C., Wong Y.C., Chandel N.S., Dienel G., et al. Neurons undergo pathogenic metabolic reprogramming in models of familial ALS. Mol. Metab. 2022;60:101468. doi: 10.1016/j.molmet.2022.101468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmet.2022.101468</ArticleId><ArticleId IdType="pmc">PMC8958550</ArticleId><ArticleId IdType="pubmed">35248787</ArticleId></ArticleIdList></Reference><Reference><Citation>Higelin J., Demestre M., Putz S., Delling J.P., Jacob C., Lutz A.K., Bausinger J., Huber A.K., Klingenstein M., Barbi G., et al. FUS Mislocalization and Vulnerability to DNA Damage in ALS Patients Derived hiPSCs and Aging Motoneurons. Front. Cell Neurosci. 2016;10:290. doi: 10.3389/fncel.2016.00290.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2016.00290</ArticleId><ArticleId IdType="pmc">PMC5183648</ArticleId><ArticleId IdType="pubmed">28082870</ArticleId></ArticleIdList></Reference><Reference><Citation>Naujock M., Stanslowsky N., Bufler S., Naumann M., Reinhardt P., Sterneckert J., Kefalakes E., Kassebaum C., Bursch F., Lojewski X., et al. 4-Aminopyridine Induced Activity Rescues Hypoexcitable Motor Neurons from Amyotrophic Lateral Sclerosis Patient-Derived Induced Pluripotent Stem Cells. Stem Cells. 2016;34:1563&#x2013;1575. doi: 10.1002/stem.2354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2354</ArticleId><ArticleId IdType="pubmed">26946488</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>